The White House Office of National Drug Control Policy yesterday released its , intended to guide federal efforts to reduce the availability and use of illicit drugs and barriers to substance use disorder treatment. 鈥淲hile this strategy reflects the President鈥檚 top priority to address the current opioid crisis and reduce the number of Americans dying from these dangerous drugs, it also sets us on the path to develop further the capability, knowledge and infrastructure to respond to the evolving nature of the drug threat as we move deeper into the twenty-first century,鈥 said James Carroll, director of national drug control policy. The strategy involves implementing a nationwide media campaign, building safe prescribing practices, expanding the use of prescription drug monitoring programs, enhancing research around evidence-based addiction treatment, eliminating barriers to treatment, combating illicit drug supply chains, and increasing the size of the addiction service workforce, among other initiatives.
 

Related News Articles

Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to鈥
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,鈥
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to鈥
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and鈥
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from鈥
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and鈥